SCHEMBL9685089

SCHEMBL9685089

CCC(OS(=O)(=O)c1ccc(C)cc1)c1ccc(C(C)=O)s1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 1/20 0.38
STAT3 P40763 1/20 0.35
PKM P14618 1/20 0.34
ALDH1A1 P00352 7/20 0.34
LMNA P02545 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
RECQL P46063 1/20 0.34
HSD17B10 Q99714 1/20 0.34
KMT2A Q03164 3/20 0.33
GAA P10253 2/20 0.33
KDM4E B2RXH2 1/20 0.33
TSHR P16473 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
GSK3B P49841 1/20 0.33
AR P10275 1/20 0.33
ENPP1 P22413 1/20 0.33
MEN1 O00255 2/20 0.33
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9685098 0.75 DHODH (0.38) DHODHSTAT3ALDH1A1LMNASMN1; SMN2
SCHEMBL10726039 0.75 DHODH (0.38) DHODHSTAT3ALDH1A1LMNASMN1; SMN2
SCHEMBL11280289 0.73 GAA (0.41) STAT3ALDH1A1KMT2AGAAMEN1
SCHEMBL10731053 0.73 HPGD (0.41) DHODHSTAT3ALDH1A1LMNARECQL
SCHEMBL10731065 0.73 HPGD (0.41) DHODHSTAT3ALDH1A1LMNARECQL
SCHEMBL13433912 0.71 KMT2A (0.40) DHODHSTAT3PKMALDH1A1LMNA
SCHEMBL7305249 0.70 ALDH1A1 (0.42) PKMALDH1A1LMNASMN1; SMN2L3MBTL1
SCHEMBL14779262 0.70 GAA (0.46) DHODHALDH1A1SMN1; SMN2KMT2AGAA
SCHEMBL4056460 0.69 HPGD (0.44) DHODHSTAT3PKMALDH1A1LMNA
SCHEMBL6686680 0.69 LMNA (0.40) DHODHSTAT3PKMALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5166218-A Antilipemic agents or antiglycemic agents HOFFMANN-LA ROCHE INC. (US) 1992-11-24 US disclosed
US-5064863-A Catabolic activity, obesity, diabetes HOFFMANN-LA ROCHE INC. (US) 1991-11-12 US disclosed
US-4871755-A Method for treating diabetes obesity and conditions characterized by increased protein breakdown with novel oxazolidines HOFFMANN-LA ROCHE INC. (US) 1989-10-03 US disclosed
US-4743604-A ANTIBESITY, ANTIDIABETIC, FEEDS HOFFMANN-LA ROCHE INC. (US) 1988-05-10 US disclosed
US-4652679-A Aziridine and phenethanolamine derivatives having antiobesity and anti-hyperglycaemic acitivity HOFFMANN-LA ROCHE INC. (US) 1987-03-24 US disclosed
US-4585796-A HYPOGLYCEMIC, ANTI-OBESITY HOFFMANN-LA ROCHE INC. (US) 1986-04-29 US disclosed